Product Information
TADALAFIL 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1043 per EA under NDC 00480230965. Its NADAC has been published 62 times since Dec 25, 2024.
FDA first approved this application on Mar 29, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480230965
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA205885FDA Approved
3/29/2019
TE Code
AB1
On Market Since
1/16/2024
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 5 MG TABLET has been published 62 times since Dec 25, 2024, and over the history we have for it it has risen 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1043 per EA |
|---|---|
| All-time high | $0.1231 (Oct 15, 2025) |
| All-time low | $0.0980 (Jan 22, 2025) |
| 52-week high | $0.1231 |
| 52-week low | $0.1043 |
| Median price | $0.1116 |
| Average price | $0.1118 |
| Largest weekly change | +9.5% (Feb 19, 2025) |
| Weeks tracked | 62 |
| Tracking since | Dec 25, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-13.3%
3Y
N/A
5Y
N/A
All
+4.0%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1043 per EA (NDC 00480230965), effective Feb 25, 2026.
How has the price of TADALAFIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has risen 4.0%. It has been tracked across 62 weekly CMS publications since Dec 25, 2024.
What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?
Since Dec 25, 2024, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0980 (Jan 22, 2025) to a high of $0.1231 (Oct 15, 2025), with a median of $0.1116 per EA.
Are there cheaper alternatives to TADALAFIL 5 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 5 MG TABLET, is $0.1022 per EA — about 2% below TADALAFIL 5 MG TABLET.
Who manufactures TADALAFIL 5 MG TABLET?
TADALAFIL 5 MG TABLET (NDC 00480230965) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.